Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers.

Immunity | 2014

Broadly neutralizing HIV antibodies are much sought after (a) to guide vaccine design, both as templates and as indicators of the authenticity of vaccine candidates, (b) to assist in structural studies, and (c) to serve as potential therapeutics. However, the number of targets on the viral envelope spike for such antibodies has been limited. Here, we describe a set of human monoclonal antibodies that define what is, to the best of our knowledge, a previously undefined target on HIV Env. The antibodies recognize a glycan-dependent epitope on the prefusion conformation of gp41 and unambiguously distinguish cleaved from uncleaved Env trimers, an important property given increasing evidence that cleavage is required for vaccine candidates that seek to mimic the functional HIV envelope spike. The availability of this set of antibodies expands the number of vaccine targets on HIV and provides reagents to characterize the native envelope spike.

Pubmed ID: 24768347 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: AI69993
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI82362
  • Agency: NIAID NIH HHS, United States
    Id: UM1 AI100663
  • Agency: NIAID NIH HHS, United States
    Id: R56 AI098484
  • Agency: NIAID NIH HHS, United States
    Id: AI095098
  • Agency: NIGMS NIH HHS, United States
    Id: GM098791
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007244
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI098602
  • Agency: NCI NIH HHS, United States
    Id: U01 CA128416
  • Agency: NIAID NIH HHS, United States
    Id: AI33232
  • Agency: NIGMS NIH HHS, United States
    Id: GM62116
  • Agency: NIGMS NIH HHS, United States
    Id: U54 GM062116
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI082362
  • Agency: NIGMS NIH HHS, United States
    Id: R24 GM098791
  • Agency: NIAID NIH HHS, United States
    Id: AI98602
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI095098
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI033292
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI114401
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI069993
  • Agency: NIAID NIH HHS, United States
    Id: AI098484

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Functional Glycomics Research (tool)

RRID:SCR_013337

This Gateway is a collaboration between the Consortium for Functional Glycomics (CFG) and Nature Publishing Group (NPG), providing a comprehensive resource for functional glycomics research. Use this site to stay up-to-date on glycomics news, request CFG resources, and search databases of glycan-binding proteins, glycan structures, and glycosyltransferases. The Functional Glycomics Update provides a one-stop overview of the latest research in glycobiology for specialists and non-specialists alike. It is updated monthly to bring you the latest news and selected highlights from Nature journals. In addition, it will provide two featured articles a month on the most relevant advances in the field published in NPG and other top journals. By collating new articles into a key worded research library, we hope to provide a continuously updated and broad overview of the field. Sponsor. The CFG is a large international research initiative funded by NIGMS to elucidate the roles of carbohydrate-protein interactions in cell communication at the cell surface.

View all literature mentions

NIH AIDS Reagent Program (tool)

RRID:SCR_023191

NIH HIV Reagent Program has been managed under contract by American Type Culture Collection (ATCC) since 2020. ATCC shall maintain the NIH HIV Reagent Program through identification, acquisition, production, receipt, storage, maintenance, distribution and disposal of biological and chemical research organisms and materials for HIV and other infectious diseases for use in basic and translational research.

View all literature mentions